Tranquility eKaryo: NIPT - Non Invasive Prenatal Trisomy Test - Electronic Karyotype
Risk free prenatal test based on cell-free DNA analysis for the detection of trisomy. Early screening ensures personalized pregnancy management and avoids the risk of unnecessary amniocentesis.
From the 10th week of pregnancy (12th for twin pregnancies), a safe prenatal screening can be performed through a simple maternal blood draw.
Features of Tranquility eKaryo:
- Maternal blood draw
- Singleton pregnancies from 10th week
- In Vitro Fertilization
- Trisomy 21, 18, 13 CE-IVD
- Baby’s sex CE-IVD
- Sex chromosomes aneuploidies
- Trisomy 9,16
- All chromosomes analysis
- Circos and electronic karyotype
- Results in 6 days + shipping time
During pregnancy, cell-free fragments of the baby’s DNA circulate in the mother’s blood. The fetal circulating cell-free DNA in maternal blood is a mix of maternal and fetal DNA. This DNA is detectable from the 5th week of gestation and its concentration increases during the following weeks.
The amount of fetal DNA present in the mother’s bloodstream is sufficient to perform the test and guarantee the accuracy of the results.
To accelerate the process, advanced method with Next-Generation Sequencing (NGS) technology allows an accurate detection of trisomy 21 (Down Syndrome) and other chromosomal disorders.
Chromosomes are represented in a circular and a karyotype layout to visualize the genomic information.
Our prenatal products include a large screening panel to detect numerical and structural chromosomal abnormalities and also identify the baby’s sex, in order to evaluate the healthy development of the baby before birth. The results report is available between 5 to 7 days.